Your browser doesn't support javascript.
loading
Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine.
Di Bona, Danilo; Miniello, Andrea; Nettis, Eustachio.
Afiliação
  • Di Bona D; Department of Emergency and Organ Transplantation, School of Allergology and Clinical Immunology, University of Bari Aldo Moro, Policlinico di Bari, Bari, Italy.
  • Miniello A; Unit of Allergology, Azienda Ospedaliero Universitaria Consorziale Policlinico, Bari Piazza Giulio Cesare, 11., 70124, Bari, Italy.
  • Nettis E; Department of Emergency and Organ Transplantation, School of Allergology and Clinical Immunology, University of Bari Aldo Moro, Policlinico di Bari, Bari, Italy.
Clin Mol Allergy ; 20(1): 13, 2022 Dec 12.
Article em En | MEDLINE | ID: mdl-36503530
Systemic drug-related intertriginous and flexural exanthema (SDRIFE) is an adverse drug reaction which manifests as a symmetrical erythematous rash involving the skin folds after systemic drug exposure. A vast array of possible side effects associated with administration of different anti-SARS-CoV-2 vaccines have been reported in literature since the beginning of the COVID-19 pandemic, but only few times SDRIFE-like eruptions have been described in this context. We discuss here a case of SDRIFE-like eruption following the second dose of Oxford-Astrazeneca Vaxzevria vaccine.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Mol Allergy Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Mol Allergy Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália